Introduction
In vivo toxicological studies of fibrous material are often complicated if not partially compromised by the problems associated with the fibrous nature of the test material. Every aspect of the study, from preparation and characterization of the test material, the mechanics of exposure and delivery, to the determination of actual dose, is subject to numerous complications that are unique to fibrous materials. In this article, we present a summary and discussion of some specific problems associated with fibrous test materials as well as our experiences on how to minimize their impact.
Fiber Counting and Measuring
Central to all aspects of experiments involving fibers is the proper characterization of the fiber. The characterization of a test fiber in terms of diameter and length distribution as well as nonfibrous content is potentially subject to a variety of biases associated with the measuring procedure used. The two most common sources of error are related to the resolution of the measuring system and the fiber selection criteria used during counting and measuring.
The ability to determine accurately the length and diameter of individual fibers depends on the measuring system employed. Optical light microscopy (OM) has a resolution limit of about 0.25 pm. This resolution limit usually is not a problem for normal bulk materials, but with material that has been specifically processed for inhalation studies to have a mean diameter of 1 to 1.5 pm a significant portion of the fiber may fall below the 0.25 pm limit. A comparison of the scanning electron microscopy (SEM) and OM diameters in Table 1 shows the effect of limited resolution when measuring typical MMVF products. Optical microscopy, either bright field or phase contrast, should not be used for counting or measuring fibers where more than a few percent of the fibers are expected to fall below 0.5 pm in diameter. Phase contrast optical microscopy (PCOM) provides a sensitive tool for identifying fine fibers but is not a satisfactory mode in which to measure fiber diameters. Fiber edges are not always distinct in the PCOM image and diameters are frequently overestimated.
EM offers a greatly improved resolution of 0.01 pm or better; however, at the high magnifications necessary to achieve this resolution, length measurements become a problem. With SEM working magnifications of x5000 to x10,000, the maximum measurable fiber length is roughly 10 to 20 pm. The truncation of longer fibers by the measuring field produces a distorted length distribution possibly obscuring the true distribution.
Transmission electron microscopy (TEM) techniques employed with asbestos are generally not applicable to glass fiber because of the latter's much greater diameter and length. As fiber aspect ratios increase accurate distributions of both length and diameter using a single technique become more difficult, and it may be necessary to employ both optical and SEM techniques.
Unless every fiber in a sample is to be measured, a bias-free technique for selecting fibers must be employed. Biases have mean lengths of 20 pm or greater. As manufactured, MMVF may contain less than 1% respirable material making it unsatisfactory for inhalation studies. To differentiate clearly between the effects of fibers versus nonfibrous particles and to maximize the respirability of the particles, the test material must undergo extensive processing. Proper milling followed by fiber sizing through air or water classification, screening, or a combination of techniques can increase the respirable content of a sample from less than 1 % to over 60%. The respirable fraction of rock and mineral wool may contain up to 60% particulates by weight and still appear relatively particulate-free in terms of particle number. High particulate contents invalidate any exposure and dose calculation based on gravimetric measurements. The size selection process, if properly executed, is also an effective method of removing nonfibrous particles. Table 2 illustrates the change in fiber dimensions that can be achieved with size selection processing.
As a general rule, surface agents should be removed prior to processing because of the possibility that they could interfere with the size selection process. Silicone oils, a common surface treatment, can be very tenacious; nevertheless, any fiber cleaning process that is used should not alter the fiber surface, either by leaching or deposition of new compounds.
Prior to any exposure the final test material must be completely characterized in terms of dimensions, chemistry, organic content, and homogeneity. Table 3 show the variation associated with sampling a fiber-water suspension containing 1 mg of fiber per milliliter of water dispersed by sonication and stirring with a surfactant. The fiber was sized to have a mean length of 25 pm and sampling was done with a micropipet having a tip bore of about 1 mm.
During instillation, the suspension is easily depleted in fiber by the formation of fiber "log jams" not only at either end of the needle but also in the trachea and upper airway of the lung (4). This "bolus effect" can result in the formation of large granulomatous lesions in the upper airways of rodents (5). Thus with fiber, unlike with particles, it is difficult to deliver a known and reproducible dose to the deep lung by instillation.
With inhalation, the process of lofting the fiber to form an aerosol cloud may significantly alter the fiber size distribution. Aerosol generators can potentially shorten brittle MMVF and reduce both the diameter and length of asbestos fibers. For reliable exposure, the aerosol cloud must be monitored in terms of mass, particle count, and fiber dimensions. For optimum results, the test material should be matched with the aerosol generation system to deliver the maximum amount of material within the target range. Table 4 compares the characteristics of stock size-selected MMVF test material with those of the aerosol generated from each. In both cases every effort was made to minimize any changes associated with the lofting process.
A satisfactory lofting process producing a stable and well characterized aerosol cloud must be established prior to exposure Numerous techniques have been employed to recover fiber from lung tissue. All of the techniques involve destruction of the tissue by the use of strong acids or bases, strong oxidizing agents such as hypochlorites and peroxides, thermal ashing, or low temperature plasma ashing. A majority of the procedures were developed to recover asbestos fiber that is very resistant to chemical attack and mechanical breakdown. MMVF is significantly less durable in all respects than asbestos (6). Furthermore, the major thrust of current MMVF research is to develop and test compositions with the lowest possible biopersistence. Techniques for recovering MMVF from tissue must be carefully designed to minimize changes in fiber chemistry or morphology. Experiments have shown that many common MMVF compositions are attacked during lung digestion. Some of the experimental compositions are even significantly etched and leached by deionized water.
The trend toward more soluble MMVF fibers presents problems not only with fiber recovery but also with tissue preservation and sample storage. Experiments have shown that MMVF has a significant solubility in a variety of tissue fixatives, including buffered formalin and Karnovsky's solution (7) . As an example of fiber loss, right accessory lobes from rats exposed to MMVF and stored for 1 year in phosphate buffered formalin contained no recoverable fiber, while those frozen immediately upon removal contained about 5 x 105 fibers/mg of dry tissue. Freezing the tissue at dry ice temperature (-20°C) immediately upon excision, without cryoprotectants, minimizes potential for degradation during storage.
Low temperature ashing (LTA) is the safest and most generally applicable technique for recovering a wide range of inorganic fibers. The residual ash with proper dispersal is suitable for all forms of optical and electron microscopy. The fiber surfaces are clean and suitable for electron probe analysis and the residual ash does not obscure the submicron fibers. One problem associated with LTA is the small but significant variability in the weight of the ash derived from the tissue. Table 5 illustrates the variation in ash weight derived from LTA treated lungs. A majority of the variation is thought to arise from variation in the amount of blood remaining. The blood forms ferric oxides with LTA, and any attempt to dissolve the oxides after ashing could also attack iron in the fiber and in ferruginous bodies. While the total ash is small, it may represent a significant portion of the total recovered weight from a lung and the variability may mask the mass of the fiber recovered. As a consequence, dose determinations based on gravimetric measurements and LTA are not reliable unless the blood is perfused from the tissue before ashing. This is not always possible, for example when adjacent tissue is to be used for histopathological examination.
Dosage of fibrous material should be characterized by more than one parameter. The recovered material can be characterized in terms of mass, fibers/mg of dry tissue, total fibers per animal or lung, fiber length, diameter, or aspect ratio, particulate content, and fiber chemistry. The more parameters that are obtained, the more useful the data will be and the greater the significance of the results.
Fiber chemistry, while not essential, is helpful in evaluating exposure and dose. The compositional analysis of fibers using energy dispersive spectroscopy with SEM is useful for identifying contamination or unknown fibers in the recovered material, especially in the negative control samples.
Any protocol used to recover fibers from tissue must be validated. Tests must be conducted to ensure that the recovered fiber is representative of, and as similar as possible to, the fiber in the living tissue before recovery. Validation is also critical in establishing the amount of variability to expect as a result of the processing, laboratory fiber background levels and their variability, upper and lower limits of useful concentration, and potential sources of contamination. Processing and quantifying microgram quantities of fiber is more art than science. The validation procedures also provide the necessary experience to quantitate successfully lung fiber burdens in an inhalation toxicology experiment.
Experience has taught us that laboratory blanks in the form of lungs from animals that were never part to the test group are essential with long-term inhalation studies. Even with the use of both positive and negative controls in the experimental group, instances of confusing and questionable data will arise. Data obtained from processing the tissue from totally uninvolved animals will provide a check on the entire tissue harvesting, processing, and analysis procedures. These data may be critical in the interpretation of apparently anomalous experimental results.
Conclusions
The starting point of any in vivo study is delivering an appropriate and well characterized dose to the target organs. When the test material is respirable fiber, both the characterization and the delivery become much more complicated than with nonfibrous particulates. The complex and only partially controllable relation between exposure and dose, whether delivered by instillation or inhalation, make verification of the actual dose delivered to the deep lung essential for the interpretation of any results.
The solubility of MMVF makes many of the techniques of tissue preservation and digestion used for asbestos fiber recovery inappropriate. Tissue preservation by freezing and fiber recovery using low temperature ashing offer a general procedure that is applicable to a variety of inorganic fiber compositions. Any technique must be validated in detail to ensure the integrity of the data and experiment.
